ORBIMED ADVISORS LLC – Terns Pharmaceuticals, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$44.06M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+137.50%
quarter
Terns Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +97.33% | 3.69M shares | 34.66M | $5.89 | 7.48M |
| Q2 2022 | share | 0.00% | 0 shares | -1.85M | $2.48 | 3.79M | |
| Q1 2022 | share | 0.00% | 0 shares | -15.54M | $2.97 | 3.79M | |
| Q4 2021 | share | 0.00% | 0 shares | -12.7M | $6.21 | 3.79M | |
| Q3 2021 | share | 0.00% | 0 shares | -6.97M | $10.42 | 3.79M | |
| Q2 2021 | share | 0.00% | 0 shares | -36.92M | $12.26 | 3.79M | |
| Q1 2021 | share | Increase | 0.00% | 3.79M shares | 83.40M | $22 | 3.79M |